(Registrant's telephone number, including area code)
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material
pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 8.01 Other Events.
On December 17, 2012, MyMedicalRecords, Inc. (the "Company") executed a Non-Exclusive Patent
License Agreement (the "Agreement") with Healthcare Holdings Group, Inc. ("Licensee") to license certain rights in
the Company's Health IT patents, including, but not limited to: U.S. Patent No. 8,321,240; U.S. Patent No.
8,301,466; U.S. Patent No. 8,117,045; U.S. Patent No. 8,117,646; and U.S. Patent No. 8,121,855, as well
as any other Health IT patents to be issued pursuant to pending applications filed by the Company in the
United States and all divisions, continuations, reissues and extensions thereof (collectively, the "Licensed
Patents"). The Agreement expires simultaneously with the last to expire of the Licensed Patents.
The Licensee will utilize the rights granted under the Licensed Patents in connection with its Health IT
business, including Licensee's products and services directed to healthcare professionals, including
ChartZoneMD ("ChartZoneMD"), an Electronic Health Records ("EHR") cloud-based
software solution, SmartFormsMD ("SmartFormsMD"), a new voice-over commanded software
module, and AccessMyRecords.com ("AMR"), an electronic storage and retrieval service for
medical and legal records that serves as the patient portal for the ChartZoneMD EHR software suite, and
other such products and services embodied in the Licensed Patents.
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this
report to be signed on its behalf by the undersigned hereunto duly authorized.
December 18, 2012
By: /s/ Robert H. Lorsch
Robert H. Lorsch
Chief Executive Officer